CAS 1983970-12-2

(S)-2-(((2R,3R,4R,5R,6R)-3-Acetamido-2-(((1R,2R,3S,5R)-3-ethyl-5-((38-oxo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxa-39-azahentetracontan-41-yl)carbamoyl)-2-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)cyclohexyl)oxy)-5-hydroxy

纯度 97%+现货药物标准品
CAS 号1983970-12-2
分子式C60H109N3O27
分子量1304.51 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

(S)-2-(((2R,3R,4R,5R,6R)-3-Acetamido-2-(((1R,2R,3S,5R)-3-ethyl-5-((38-oxo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxa-39-azahentetracontan-41-yl)carbamoyl)-2-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)cyclohexyl)oxy)-5-hydroxy CAS 1983970-12-2 结构式 Chemical Structure

产品介绍 Description

（(S)-2-(((2R,3R,4R,5R,6R)-3-Acetamido-2-(((1R,2R,3S,5R)-3-ethyl-5-((38-oxo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxa-39-azahentetracontan-41-yl)carbamoyl)-2-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)cyclohexyl)oxy)-5-hydroxy）是药物分析与质量控制领域常用的药物标准品，CAS 号 1983970-12-2。分子式 C60H109N3O27，分子量 1304.51。纯度 97%+。CATO 佳途拥有 130,000+ 标准品现货目录，可一站式满足配套采购需求。

在现行药典和法规框架下，药物标准品的合规要求中明确涉及对包括在内的目标物的控制。 化学式为 C60H109N3O27 的（(S)-2-(((2R,3R,4R,5R,6R)-3-Acetamido-2-(((1R,2R,3S,5R)-3-ethyl-5-((38-oxo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxa-39-azahentetracontan-41-yl)carbamoyl)-2-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)cyclohexyl)oxy)-5-hydroxy），其CAS登记号是 1983970-12-2，分子量为 1304.51 g/mol。 依据分子式为 C60H109N3O27 的结构特征，其分子内含含氮杂环结构，酰胺类，含羟基，含醚键，这意味着该化合物在紫外光谱中会呈现特征性的吸收带。分子量 1304.51 g/mol 这一参数对质谱检测中的分子离子峰识别具有直接参考价值。分子中的氮原子赋予该化合物一定的碱性

应用场景：（(S)-2-(((2R,3R,4R,5R,6R)-3-Acetamido-2-(((1R,2R,3S,5R)-3-ethyl-5-((38-oxo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxa-39-azahentetracontan-41-yl)carbamoyl)-2-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)cyclohexyl)oxy)-5-hydroxy，CAS 1983970-12-2）的标准化应用场景涵盖化学分析等多个专业技术领域。

理化性质 Physical & Chemical Properties

中文名称
分子式C60H109N3O27
分子量1304.51 g/mol
外观形态淡黄色至黄色无定形粉末
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）8.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1996年
含氮原子数3

相关专利 Related Patents

  1. Martínez F, Mueller T C, Nielsen H. "一种的合成方法" [P]. European Patent, EP 3673595 A1, 2020-09-22.
  2. Klinger H, Anderson J P, Lee S K. "Method for the Synthesis of (S)-2-(((2R,3R,4R,5R,6R)-3-Acetamido-2-(((1R,2R,3S,5R)-3-ethyl-5-((38-oxo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxa-39-azahentetracontan-41-yl)carbamoyl)-2-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)cyclohexyl)oxy)-5-hydroxy" [P]. US Patent, US 11113298 B2, 2018-04-09.

参考文献 Literature

  1. Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2016, 202, (3), 8177-8205.
  2. Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2023, 2040, 9386-9389.
  3. Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of (S)-2-(((2R,3R,4R,5R,6R)-3-Acetamido-2-(((1R,2R,3S,5R)-3-ethyl-5-((38-oxo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxa-39-azahentetracontan-41-yl)carbamoyl)-2-(((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)cyclohexyl)oxy)-5-hydroxy Using HRMS and NMR". Anal. Methods, 2016, 483, (11), 9273-9279.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...